WASHINGTON — The Supreme Court on Monday maintained full access to the abortion pill mifepristone while it continues to mull how to rule in a case that could limit availability of the drug.
Subscribe to read this story ad-free
Get unlimited access to ad-free articles and exclusive content.
The court on May 4, via an order issued by Justice Samuel Alito, had provisionally blocked a lower court decision that would have prevented the pill from being administered by mail.
Alito on Monday extended the pause until 5 p.m. on Thursday, giving the court another four days to consider its next steps.
The nationwide availability of mifepristone was cast into jeopardy when the New Orleans-based 5th U.S. Circuit Court of Appeals granted Louisiana’s request to void Biden administration rules that allowed the drug to be administered without an in-person meeting, meaning it can in theory be mailed anywhere in the country, even in states with strict abortion bans.
This is a developing story. Please check back for updates.
